Alzamend Neuro, Inc.
Clinical trials sponsored by Alzamend Neuro, Inc., explained in plain language.
-
Could a custom vaccine slow Alzheimer's? new trial begins
Disease control OngoingThis study tests a new treatment called ALZN002 for people with mild-to-moderate Alzheimer's. It uses a person's own immune cells to target harmful proteins in the brain. The goal is to see if it is safe and can help control the disease. About 30 volunteers aged 60 to 85 will tak…
Phase: PHASE1, PHASE2 • Sponsor: Alzamend Neuro, Inc. • Aim: Disease control
Last updated May 26, 2026 11:24 UTC
-
New lithium formula tested for brain uptake in healthy adults
Knowledge-focused OngoingThis early-stage study tests a new crystallized lithium capsule (AL001) against standard lithium carbonate in 6 healthy adults. Participants take each drug for 14 days and undergo MRIs and blood draws to compare how much lithium reaches the brain. The goal is to see if AL001 is s…
Phase: PHASE1 • Sponsor: Alzamend Neuro, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 11:23 UTC